catalyst
as of 2026-07-01Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophr — primary completion
at a glance
2016-09 · Estimated (est.) — Registry-estimated date, not yet actual.
Synthesized from structured facts only — each point cited above.
Event
What
Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophr — primary completion
Type
Trial Readout
Date
2016-09
Date type
ESTIMATED est.
Phase
Phase 1,PHASE2
Registry-estimated date, not yet actual. This date is directional and must not be read as settled.
relationships
The graph out of here